Abstract:Floxuridine (FUdR, 5-fluoro-2-deoxyuridine) was widely used in patients with tumor. But the poor activity and severe side effects have been observed in the clinic, which resulted from increased degradation cleavage of FUdR to 5-FU by thymidine phosphorylase and reduced transporter-mediated entry into cells. In this study, we have synthesized a series of l-aspartic acid β-esters and l-glutamic acid γ-esters of FUdR to improve the metabolic stability of FUdR and target FUdR to cancer cells via amino acid transporter ATB0,+ which was exclusively up-regulated in some cancerous tissue. The uptake mechanism, stability, in vitro/in vivo antiproliferation action, pharmacokinetics, and tissue distribution were studied. The combined results showed the unusual 5′-β-l-Asp-FUdR possessed a better tumor inhibition rate and a better metabolic stability than FUdR through a ATB0,+-mediated prodrug approach. The present study provided the first proof-of-concept of exploiting ATB0,+ for tumor-selective delivery of nucleoside analogues in the form of prodrug.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00149?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00149</a>.1H NMR (400 MHz, DMSO-d6), 13C NMR (100 MHz, DMSO-d6), and HPLC of 5′-α-l-Val-FUdR, 3′-α-l-Val-FUdR, 3′,5′-di-α-l-Val-FUdR, 5′-β-l-Asp-FUdR, 3′-β-l-Asp-FUdR, 3′,5′-di-β-l-Asp-FUdR, 5′-γ-l-Glu-FUdR, 3′-γ-l-Glu-FUdR, and 3′,5′-di-γ-l-Glu-FUdR (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00149/suppl_file/jm0c00149_si_001.pdf">PDF</a>)Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00149/suppl_file/jm0c00149_si_002.csv">CSV</a>)Coordinates of homology models for ATB0,+ (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00149/suppl_file/jm0c00149_si_003.pdb">PDB</a>)This article has not yet been cited by other publications.

Surface decoration of PLGA nanoparticles enables efficient transport of floxuridine oligomers into mammalian cells

Esterase-Responsive Floxuridine-Tethered Multifunctional Nanoparticles for Targeted Cancer Therapy

PLGA Nanoparticles for the Oral Delivery of 5-Fluorouracil Using High Pressure Homogenization-Emulsification as the Preparation Method and In Vitro/In Vivo Studies

5-Fluorouracil-Loaded PLGA Nanoparticles: Formulation, Physicochemical Characterisation, and In VitroAnti-Cancer Activity

Folate-functionalized nanoparticles for controlled 5-Fluorouracil delivery.

Preparation of novel sulfated polysaccharide-carboxymethyl-5-fluorouracil-folic acid conjugates for targeted anticancer drug delivery

Self-assembled nanoparticles from folate-decorated maleilated pullulan-doxorubicin conjugate for improved drug delivery to cancer cells

Polyplex nanovesicles of single strand oligonucleotides for efficient cytosolic delivery of biomacromolecules

Affibody-Conjugated RALA Polymers Delivering Oligomeric 5-Fluorodeoxyuridine for Targeted Therapy of HER2 Overexpressing Gastric Cancer.

Optimized 5-Fluorouridine Prodrug for Co-Loading with Doxorubicin in Clinically Relevant Liposomes

Oligo-guanidyl targeted bioconjugates forming rod shaped polyplexes as a new nanoplatform for oligonucleotide delivery

Nanodroplets Engineered with Folate Carbon Dots for Enhanced Cancer Cell Uptake toward Theranostic Application

Folic Acid-Targeted Polydopamine-Based Surface Modification of Mesoporous Silica Nanoparticles As Delivery Vehicles for Cancer Therapy

Dextran-based nanoparticles with 5-FU-conjugated polymethacrylate segments for drug delivery: Synthesis of amphiphilic graft copolymers by mechanochemical solid-state polymerization and characterization

Two-step Synthesis of Structure-Diverse D-Galactose Conjugates and Polymeric Prodrugs of Floxuridine Via Controllable Regioselective Enzymatic Acylation of 3′- or 5′-OH Group of Floxuridine

Production of 5-fluorouracil-loaded PLGA nanoparticles with toroidal microfluidic system and optimization of process variables by design of experiments

Delivery of oxaliplatin to colorectal cancer cells by folate-targeted UiO-66-NH2

Synthesis of folate targeted theranostic cubosomal platform for co-delivery of bismuth oxide and doxorubicin to melanoma in vitro and in vivo

Bifunctional and Unusual Amino Acid β- or γ-Ester Prodrugs of Nucleoside Analogues for Improved Affinity to ATB 0,+ and Enhanced Metabolic Stability: An Application to Floxuridine

Dual tumor-targeted poly(lactic-co-glycolic acid)-polyethylene glycol-folic acid nanoparticles: a novel biodegradable nanocarrier for secure and efficient antitumor drug delivery.

PEG-modified Fe2O3 coated agarose hydrogel: A synthesized nanocomposite for regulated 5-fluorouracil delivery